Short communication| Volume 50, ISSUE 8, P788-790, December 2012

Download started.


Cytogenetics of primary embryonal rhabdomyosarcoma of the cheek

Published:January 27, 2012DOI:


      Rhabdomyosarcoma (RMS) is the most common malignant soft tissue tumour of childhood and has two main subtypes: embryonal and alveolar. The embryonal subtype accounts for most cases in the genitourinary tract and head and neck. Oral presentations are rare, and mainly in the tongue, palate, or cheek. Cytogenetically, alveolar RMS is characterised by the translocation t(2;13)(q35;q14), which plays an important part in diagnosis, but no consistent and unique genetic alterations have been identified in embryonal RMS. It is currently not known whether oral embryonal RMS is similar to those that arise from other sites, as only one cytogenetic report has been published to date. We present the case of a 9-year-old boy with embryonal RMS of the cheek, and discuss the cytogenetic alterations in his case.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Wang C.
        Childhood rhabdomyosarcoma: recent advances and prospective views.
        J Dent Res. 2011;
        • Chigurupati R.
        • Alfatooni A.
        • Myall R.W.
        • Hawkins D.
        • Oda D.
        Orofacial rhabdomyosarcoma in neonates and young children: a review of the literature and management of four cases.
        Oral Oncol. 2002; 38: 508-515
        • Fatusi O.A.
        • Ajike S.O.
        • Olateju S.O.
        • Adebajo A.T.
        • Gbolahan O.O.
        • Ogunmuyiwa S.A.
        Clinico-epidemiological analysis of orofacial rhabdomyosarcoma in a Nigerian population.
        Int J Oral Maxillofac Surg. 2009; 38: 256-260
        • Grundy R.
        • Anderson J.
        • Gaze M.
        • Gerrard M.
        • Glaser A.
        • Gordon A.
        • et al.
        Congenital alveolar rhabdomyosarcoma: clinical and molecular distinction from alveolar rhabdomyosarcoma in older children.
        Cancer. 2001; 91: 606-612
        • Wachtel M.
        • Detting M.
        • Koscielniak E.
        • Stegmaier S.
        • Treuner J.
        • Simon-Klingenstein K.
        • et al.
        Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusion PAX3 to NCOA1.
        Cancer Res. 2004; 64: 5539-5545
        • Limwongse C.
        • Schwartz S.
        • Bocian M.
        • Robin N.H.
        Child with mosaic variegated aneuploidity and embryonal rhabdomyosarcoma.
        Am J Med Genet. 1999; 82: 20-24
        • Manor E.
        • Bodner L.
        • Kachko P.
        • Kapelushnik J.
        Trisomy 8 as a sole aberration in embryonal rhabdomyosarcoma (sarcoma botryoides) of the vagina.
        Cancer Genet Cytogenet. 2009; 195: 172-174
      1. Shaffer L.G. Slovak M.L. Campbell L.J. An International System for Human Cytogenetic Nomenclature. Karger, Basel2009
        • Moller P.
        • Perrier M.
        Dentomaxillofacial sequelae in a child treated for a rhabdomyosarcoma in head and neck.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86: 297-303
        • Gil-Benson R.
        • Lopez-Gines C.
        • Carda C.
        • Lopez-Guerrero J.A.
        • Ferrer J.
        • Pellin-Perez A.
        • et al.
        Cytogenetic and molecular findings related to rhabdomyosarcoma. An analysis of seven cases.
        Cancer Genet Cytogenet. 2003; 144: 125-133